Haase S - Search Results

1

Lenalidomide in the context of complex karyotype or interrupted treatment: case reviews of del(5q)MDS patients with unexpected responses.

Giagounidis AA, Haase S, Heinsch M, Göhring G, Schlegelberger B, Aul C. Giagounidis AA, et al. Among authors: haase s. Ann Hematol. 2007 Feb;86(2):133-7. doi: 10.1007/s00277-006-0217-y. Epub 2006 Nov 17. Ann Hematol. 2007. PMID: 17111142 Free PMC article.

2

Treatment of myelodysplastic syndrome with isolated del(5q) including bands q31-q33 with a combination of all-trans-retinoic acid and tocopherol-alpha: a phase II study.

Giagounidis AA, Haase S, Germing U, Schlegelberger B, Wilkens L, Büsche G, Kreipe HH, Wysk J, Grips KH, Grabenhorst U, Rothmann F, Lübbert M, Ganser A, Aivado M, Heinsch M, Aul C. Giagounidis AA, et al. Among authors: haase s. Ann Hematol. 2005 Jun;84(6):389-94. doi: 10.1007/s00277-005-1027-3. Epub 2005 Mar 23. Ann Hematol. 2005. PMID: 15785949 Clinical Trial.

3

Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31.

Giagounidis AA, Germing U, Haase S, Hildebrandt B, Schlegelberger B, Schoch C, Wilkens L, Heinsch M, Willems H, Aivado M, Aul C. Giagounidis AA, et al. Among authors: haase s. Leukemia. 2004 Jan;18(1):113-9. doi: 10.1038/sj.leu.2403189. Leukemia. 2004. PMID: 14586479

4

Early plasmacytoid dendritic cell leukemia/lymphoma coexpressing myeloid antigenes.

Giagounidis AA, Heinsch M, Haase S, Aul C. Giagounidis AA, et al. Among authors: haase s. Ann Hematol. 2004 Nov;83(11):716-21. doi: 10.1007/s00277-004-0913-4. Epub 2004 Aug 5. Ann Hematol. 2004. PMID: 15316755

5

Autoimmune disorders in two patients with myelodysplastic syndrome and 5q deletion.

Giagounidis AA, Haase S, Germing U, Heinsch M, Aul C. Giagounidis AA, et al. Among authors: haase s. Acta Haematol. 2005;113(2):146-9. doi: 10.1159/000083454. Acta Haematol. 2005. PMID: 15802895

6

Lenalidomide: a brief review of its therapeutic potential in myelodysplastic syndromes.

Giagounidis AA, Germing U, Haase S, Aul C. Giagounidis AA, et al. Among authors: haase s. Ther Clin Risk Manag. 2007 Aug;3(4):553-62. Ther Clin Risk Manag. 2007. PMID: 18472976 Free PMC article.

7

Where Does Morphology Fit in Myelodysplastic Syndrome Diagnosis in the Era of Molecular Testing?

Giagounidis A, Haase S. Giagounidis A, et al. Among authors: haase s. Hematol Oncol Clin North Am. 2020 Apr;34(2):321-331. doi: 10.1016/j.hoc.2019.11.005. Epub 2020 Jan 21. Hematol Oncol Clin North Am. 2020. PMID: 32089213 Review.

8

Identification of disease- and therapy-associated proteome changes in the sera of patients with myelodysplastic syndromes and del(5q).

Chen C, Bowen DT, Giagounidis AA, Schlegelberger B, Haase S, Wright EG. Chen C, et al. Among authors: haase s. Leukemia. 2010 Nov;24(11):1875-84. doi: 10.1038/leu.2010.182. Epub 2010 Aug 26. Leukemia. 2010. PMID: 20739954

9

Long-term transfusion independence in del(5q) MDS patients who discontinue lenalidomide.

Giagounidis AA, Kulasekararaj A, Germing U, Radkowski R, Haase S, Petersen P, Göhring G, Büsche G, Aul C, Mufti GJ, Platzbecker U. Giagounidis AA, et al. Among authors: haase s. Leukemia. 2012 Apr;26(4):855-8. doi: 10.1038/leu.2011.268. Epub 2011 Sep 30. Leukemia. 2012. PMID: 21960245 No abstract available.

10

Dasatinib induces complete remission in a patient with primary cerebral involvement of B-cell chronic lymphocytic leukemia failing chemotherapy.

Russwurm G, Heinsch M, Radkowski R, Erlemann R, Aul C, Haase S, Giagounidis A. Russwurm G, et al. Among authors: haase s. Blood. 2010 Oct 7;116(14):2617-8. doi: 10.1182/blood-2010-04-279786. Blood. 2010. PMID: 20930084 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

322 results

Search Page